Epstein Secrets

or rebounding slightly off a three-year low, the first uptick since Feb but still indicating a 'Buy" 0. The indicators expected 12m return is +21%. Daniel Lundquist Healthcare Specialist Sales Global Equities Bank of America Merrill Lynch One Bryant Park I New York, 10036 I United States The power of global

hat our analyst hosted (see link) as our sector specialist was up in Boston for the meeting. M&A is one of the primary reasons why we're BULLISH on Biotech — more in the write-up from yesterday on the Fear of Missing Biotech Basket — MLDIFOMB. From: Ens, Amanda Sent: Monday, August 01, 2016 2:53 PM T

r rebounding slightly off a three-year low, the first =ptick since Feb but still indicating a "Buy" (). =he indicators expected 12m return is +21%. Daniel Lundquist Healthcare Specialist Sales Global Equities Bank of America Merrill Lynch One Bryant Park I New York, 10036 I United States The power of global

hat our analyst hosted (see link) as our sector specialist was up in Boston for the meeting. M&A is one of the =rimary reasons why we're BULLISH on Biotech — more in =he write-up from yesterday on the Fear of Missing Biotech Basket —=MLDIFOMB. From: Ens, Amanda Sent: Monday, August 01, 2016 2:53 PM T

the HIX ($14.3bn in 2018), Medtech Tax (2.3%), pharma industry tax ($4.1bn in 2018) & Cadillac tax (effective 2020). As for the views by analysts... Biotech (+) — believe sector will outperform largely as pricing risk has diminished (although will remain in pockets) but pipelines/growth remains. Ying’s to

pharmacies CVS/WBA given benefits from decelerating generic prices (which will remain an overhang for Distributors). HHS appointment a —ve for HCIT. Daniel Lundquist Healthcare Specialist Sales Global Equities Bank of America Merrill Lynch One Bryant Park | New York, 10036 | United States T: M: The power of gl